Abstract
The ten years since the first publications on the human microbiome project have brought enormous attention and insight into the role of the human microbiome in health and disease. Connections between populations of microbiota and ocular disease are now being established, and increased accessibility to microbiome research and insights into other diseases is expected to yield enormous information in the coming years. With the characterization of the ocular microbiome, important insights have already been made regarding corneal and conjunctival tissues. Roles for non-ocular microbiomes in complex retinal diseases are now being evaluated. For example, the gut microbiome has been implicated in the pathogenesis of uveitis. This short review will summarize the few studies linking gut or oral microbiota to diabetic retinopathy (DR), glaucoma, and age-related macular degeneration (AMD). We will also conjecture where the most significant findings still remain to be elucidated. Finally, we will propose the gut-retina axis, related but distinct from the gut-brain axis.
Keywords
- Gut microbiome
- Oral microbiome
- Microbiota
- Gut dysbiosis
- Age-related macular degeneration
- Diabetic retinopathy
- Glaucoma
- Uveitis
- Glycemic index
- Gut-retina axis
This is a preview of subscription content, access via your institution.
Buying options

References
Allin KH, Nielsen T, Pedersen O (2015) Mechanisms in endocrinology: gut microbiota in patients with type 2 diabetes mellitus. Eur J Endocrinol 172:R167–R177
Arora T, Backhed F (2016) The gut microbiota and metabolic disease: current understanding and future perspectives. J Intern Med 280:339–349
Astafurov K, Elhawy E, Ren L et al (2014) Oral microbiome link to neurodegeneration in glaucoma. PLoS One 9:e104416
Clemente JC, Ursell LK, Parfrey LW et al (2012) The impact of the gut microbiota on human health: an integrative view. Cell 148:1258–1270
Forslund K, Hildebrand F, Nielsen T et al (2015) Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature 528:262–266
Ghaisas S, Maher J, Kanthasamy A (2016) Gut microbiome in health and disease: linking the microbiome-gut-brain axis and environmental factors in the pathogenesis of systemic and neurodegenerative diseases. Pharmacol Ther 158:52–62
Horai R, Zarate-Blades CR, Dillenburg-Pilla P et al (2015) Microbiota-dependent activation of an autoreactive T cell receptor provokes autoimmunity in an immunologically privileged site. Immunity 43:343–353
Kaarniranta K, Salminen A, Haapasalo A et al (2011) Age-related macular degeneration (AMD): Alzheimer’s disease in the eye? J Alzheimers Dis 24:615–631
Karlsson FH, Tremaroli V, Nookaew I et al (2013) Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 498:99–103
Kim JM, Kim SH, Park KH et al (2011) Investigation of the association between Helicobacter pylori infection and normal tension glaucoma. Invest Ophthalmol Vis Sci 52:665–668
Kountouras J, Mylopoulos N, Konstas AG et al (2003) Increased levels of Helicobacter pylori IgG antibodies in aqueous humor of patients with primary open-angle and exfoliation glaucoma. Graefes Arch Clin Exp Ophthalmol 241:884–890
Kugadas A, Gadjeva M (2016) Impact of microbiome on ocular health. Ocul Surf 14:342–349
Lee H, Ko G (2014) Effect of metformin on metabolic improvement and gut microbiota. Appl Environ Microbiol 80:5935–5943
Lu LJ, Liu J (2016) Human microbiota and ophthalmic disease. Yale J Biol Med 89:325–330
Mayer EA, Tillisch K, Gupta A (2015) Gut/brain axis and the microbiota. J Clin Invest 125:926–938
McCreight LJ, Bailey CJ, Pearson ER (2016) Metformin and the gastrointestinal tract. Diabetologia 59:426–435
Munie M, Ryu C, Noorulla S et al (2014) Effect of metformin on the development and severity of diabetic retinopathy. Invest Ophthalmol Vis Sci 55:ARVO e-abstract 1069
Nakamura YK, Metea C, Karstens L et al (2016) Gut microbial alterations associated with protection from autoimmune uveitis. Invest Ophthalmol Vis Sci 57:3747–3758
Neu J (2013) The microbiome and its impact on disease in the preterm patient. Curr Pediatr Rep 1:215–221
O’Mahony SM, Clarke G, Borre YE et al (2015) Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behav Brain Res 277:32–48
Oresic M, Seppanen-Laakso T, Yetukuri L et al (2009) Gut microbiota affects lens and retinal lipid composition. Exp Eye Res 89:604–607
Qin J, Li Y, Cai Z et al (2012) A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490:55–60
Rosenbaum JT, Lin P, Asquith M (2016) The microbiome, HLA, and the pathogenesis of uveitis. Jpn J Ophthalmol 60:1–6
Sacca SC, Vagge A, Pulliero A et al (2014) Helicobacter pylori infection and eye diseases: a systematic review. Medicine (Baltimore) 93:e216
Uchiki T, Weikel KA, Jiao W et al (2012) Glycation-altered proteolysis as a pathobiologic mechanism that links dietary glycemic index, aging, and age-related disease (in non diabetics). Aging Cell 11:1–13
Weikel KA, Chiu CJ, Taylor A (2012a) Nutritional modulation of age-related macular degeneration. Mol Asp Med 33:318–375
Weikel KA, Fitzgerald P, Shang F et al (2012b) Natural history of age-related retinal lesions that precede AMD in mice fed high or low glycemic index diets. Invest Ophthalmol Vis Sci 53:622–632
Yang C, Fei Y, Qin Y et al (2015) Bacterial flora changes in conjunctiva of rats with streptozotocin-induced type I diabetes. PLoS One 10:e0133021
Yi QY, Deng G, Chen N et al (2016) Metformin inhibits development of diabetic retinopathy through inducing alternative splicing of VEGF-A. Am J Transl Res 8:3947–3954
Zeng J, Liu H, Liu X et al (2015) The relationship between Helicobacter pylori infection and open-angle glaucoma: a meta-analysis. Invest Ophthalmol Vis Sci 56:5238–5245
Zullo A, Ridola L, Hassan C et al (2012) Glaucoma and Helicobacter pylori: eyes wide shut? Dig Liver Dis 44:627–628
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this paper
Cite this paper
Rowan, S., Taylor, A. (2018). The Role of Microbiota in Retinal Disease. In: Ash, J., Anderson, R., LaVail, M., Bowes Rickman, C., Hollyfield, J., Grimm, C. (eds) Retinal Degenerative Diseases. Advances in Experimental Medicine and Biology, vol 1074. Springer, Cham. https://doi.org/10.1007/978-3-319-75402-4_53
Download citation
DOI: https://doi.org/10.1007/978-3-319-75402-4_53
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-75401-7
Online ISBN: 978-3-319-75402-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)